Europe aims to get vaccinations back on track after clearing AstraZeneca shot | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
May 29, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, MAY 29, 2025
Europe aims to get vaccinations back on track after clearing AstraZeneca shot

Coronavirus chronicle

Reuters
19 March, 2021, 09:20 am
Last modified: 19 March, 2021, 08:24 pm

Related News

  • Macron navigates rocky path to recognising Palestinian state
  • German court to rule on Peruvian farmer versus RWE climate case
  • France's Macron, Indonesia's Prabowo to discuss defence ties
  • Germany threatens steps against Israel as tone shifts over Gaza
  • Germany shifts tone on Israel over 'incomprehensible' Gaza carnage

Europe aims to get vaccinations back on track after clearing AstraZeneca shot

Safety concerns had led at least 13 European countries to stop administering the shot, slowing an already faltering inoculation campaign across the European Union, which is lagging Britain and the United States

Reuters
19 March, 2021, 09:20 am
Last modified: 19 March, 2021, 08:24 pm
A person receives a dose of Oxford/AstraZeneca's Covid-19 vaccine at a vaccination centre in Antwerp, Belgium March 18, 2021. Reuters/Yves Herman
A person receives a dose of Oxford/AstraZeneca's Covid-19 vaccine at a vaccination centre in Antwerp, Belgium March 18, 2021. Reuters/Yves Herman

Europe pushed to get its Covid-19 vaccination drive back on track on Friday after EU and British regulators said the benefits of AstraZeneca's shot outweighed any risks following reports of blood clots.

The end to the suspension of AstraZeneca shots by more than a dozen countries will now kick off a test of public confidence, both in the vaccine and regulators who are under unprecedented scrutiny as variants of the virus spread and the global death toll climbs beyond 2.8 million.

Safety concerns had led at least 13 European countries to stop administering the shot, slowing an already faltering inoculation campaign across the European Union, which is lagging Britain and the United States.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Europe's leaders say they need to accelerate their vaccination drive, with deaths in the EU topping 550,000, less than a 10th of the bloc's population inoculated and growing signs of an imminent third wave of infections.

Germany, Italy and others countries including Indonesia began on Friday to administer the shots they had suspended after reports of about 30 cases of rare brain blood clots sent scientists and governments scrambling to determine any link.

France's health regulator, however, recommended only over 55s should get AstraZeneca shots due to concern those younger were more at risk of clots while Lithuania will let people chose their vaccine in a possible litmus test of sentiment.

The European Medicines Agency (EMA) came to what it called a clear conclusion that the vaccine's benefits in protecting people from coronavirus-related death or hospitalisation outweighed the possible risks.

Still, EMA said a link between rare events of blood clots in the brain and the shot could not be definitively ruled out and it would continue its scrutiny, as will the British Medicines and Healthcare products Regulatory Agency (MHRA).

"This is a safe and effective vaccine," EMA Director Emer Cooke told a briefing on Thursday. "If it were me, I would be vaccinated tomorrow."

Prudent Reintroduction

The EMA said it would update its guidance on the vaccine to include an explanation for patients about potential risks and information for healthcare professionals to help people recognise when they may need medical assistance.

Germany resumed administering the vaccine on Friday morning after a three-day pause as the nation's health minister warned there were not enough vaccines in Europe to contain a third wave of coronavirus infections. 

"We can reintroduce AstraZeneca but prudently with informed doctors and appropriately educated citizens," Health Minister Jens Spahn said.

In Italy, where Prime Minister Mario Draghi said the country was also resuming vaccinations with AstraZeneca's shot, about 200,000 inoculations had been put on hold due leaving regions in control of inoculations to reschedule them.

"They already have the doses, it's not like we have to distribute more today," an Italian health ministry spokesman said.

Spain will resume inoculations from Wednesday with the Netherlands also planning to start using AstraZeneca shots again next week.

Canada also gave its backing to the vaccine though Denmark and Sweden both said they needed more time to make a decision.

French Prime Minister Jean Castex said he would get the shot on Friday to try to promote acceptance. Still, the country's recommendation for giving the shot only to those 55 and older reflects a lingering reluctance.

"The EMA has identified a possible increased risk of (thrombosis) in people under 55 years old," the country's drug regulator said.

Georgia said coronavirus vaccinations with the AstraZeneca shot would continue only in fully-fledged medical centres following the death of a nurse who suffered an anaphylactic shock, according to regional news agencies.

The central African country of Cameroon, meanwhile, suspended the AstraZeneca vaccine on Friday, saying it was a precautionary move, without providing specifics.

'Incredibly Reassuring'

Amid a mixed global picture, some experts sought to reinforce confidence in AstraZeneca's vaccine, which is seen as an important asset globally due to its relatively easy storage and transport requirements and low price compared to mRNA vaccines made by Pfizer and Moderna.

"What we really should be focusing on is that this is incredibly reassuring. The processes are working, the safety monitoring that we all expect from our authorities is happening," Andrew Pollard, who runs the Oxford Vaccine Group, told BBC radio.

"We do need to continue to monitor safety, but in the end it's the virus we're fighting, not the vaccines."

Oxford University partnered with AstraZeneca to develop the vaccine.

Britain's MHRA is investigating five cases of the rare brain blood clot among 11 million shots administered in the country.

The MHRA, like the EMA, said it would scrutinise reports of clots in the cerebral veins - know as sinus vein thrombosis, or CSVT - occurring together with lowered platelets soon after vaccination.

But the agency said the vaccine should continue to be used and one official said Britain's roll-out would probably carry on even if a link were proven.

The drugmaker's own review covering more than 17 million people who have received its shot in the EU and Britain found no evidence of increased risk of blood clots.

The World Health Organization, which this week reaffirmed its support for the shot that remains a centrepiece of its COVAX vaccine sharing programme, plans on Friday to give an update on its vaccine advisory committee's review.

Top News / World+Biz

Germany / France / AstraZeneca / resume

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • US President Donald Trump speaks during a swearing-in ceremony of Special Envoy Steve Witkoff in the Oval Office at the White House in Washington, DC, US, May 6, 2025. REUTERS/Kent Nishimura/File Photo
    US court blocks most Trump tariffs, says president exceeded his authority
  • Infograph: TBS
    Businesses set for relief as interim govt eyes major tax & fine cuts
  • File photo of Bangladesh Secretariat. Photo: Collected
    Visitors banned from entering Secretariat on Mondays and Thursdays

MOST VIEWED

  • Google Pay. Photo: Collected
    Google Pay likely coming to Bangladesh soon
  • IFIC Bank receives Tk6,000 cr in new deposits in six months
    IFIC Bank receives Tk6,000 cr in new deposits in six months
  • Dhaka areas at a gridlock on Wednesday, 28 May 2025. Photo: Syed Zakir Hossain/TBS
    BNP, Jamaat rallies: Traffic clogs Dhaka roads, including Motijheel, Paltan, Dainik Bangla intersection
  • Abdul Awal Mintoo, chairman of National Bank Limited. Sketch: TBS
    'Regulatory support must for National Bank to restore depositors' confidence'
  • Mohammad Abdul Mannan, chairman FSIB Ltd. Sketch: TBS
    FSIB to bounce back soon
  • Mohammad Mamdudur Rashid, managing director and CEO, UCB. Sketch: TBS
    Customers’ trust and confidence fueling deposit growth at UCB

Related News

  • Macron navigates rocky path to recognising Palestinian state
  • German court to rule on Peruvian farmer versus RWE climate case
  • France's Macron, Indonesia's Prabowo to discuss defence ties
  • Germany threatens steps against Israel as tone shifts over Gaza
  • Germany shifts tone on Israel over 'incomprehensible' Gaza carnage

Features

In recent years, the Gor-e-Shaheed Eidgah has emerged as a strong contender for the crown of the biggest Eid congregation in the country, having hosted 600,000 worshippers in 2017. Photo: TBS

Gor-e-Shaheed Boro Maath: The heart of Dinajpur

2d | Panorama
The Hili Land Port, officially opened in 1997 but with trade roots stretching back to before Partition, has grown into a cornerstone of bilateral commerce.

Dhaka-Delhi tensions ripple across Hili’s markets and livelihoods

3d | Panorama
Photo: Collected

Desk goals: Affordable ways to elevate your study setup

3d | Brands
Built on a diamond-type frame, the Hornet 2.0 is agile but grounded. PHOTO: Asif Chowdhury

Honda Hornet 2.0: Same spirit, upgraded sting

3d | Wheels

More Videos from TBS

The fight between two brothers; Adidas vs Puma

The fight between two brothers; Adidas vs Puma

9h | Others
Trump is again keen to make Canada the 51st state

Trump is again keen to make Canada the 51st state

10h | Others
Trump's tariff strategy and Europe's investment politics, violence or negotiation?

Trump's tariff strategy and Europe's investment politics, violence or negotiation?

11h | Others
Rumours surrounding the Club World Cup: Which club will Ronaldo join?

Rumours surrounding the Club World Cup: Which club will Ronaldo join?

12h | Others
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net